IGC Pharma
IGC
#10741
Rank
A$30.52 M
Marketcap
A$0.30
Share price
2.20%
Change (1 day)
-49.48%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

IGC Pharma (IGC) - Total assets

Total assets on the balance sheet as of March 2026 : A$13.26 Million

According to IGC Pharma's latest financial reports the company's total assets are A$13.26 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

IGC Pharma - Total assets on balance sheet (from 2006 to 2024)

Total assets by year

Year Total assets Change
2023-03-31A$25.64 M-28.39%
2022-03-31A$35.81 M-24.16%
2021-03-31A$47.23 M0%
2020-03-31A$47.22 M-2.52%
2019-03-31A$48.44 M242.97%
2018-03-31A$14.12 M-4.28%
2017-03-31A$14.75 M-39.98%
2016-03-31A$24.58 M-7.92%
2015-03-31A$26.7 M39.56%
2014-03-31A$19.13 M3.48%
2013-03-31A$18.49 M-24.02%
2012-03-31A$24.33 M38.46%
2011-03-31A$17.57 M-54.25%
2010-03-31A$38.41 M-48.19%
2009-03-31A$74.15 M0.99%
2008-03-31A$73.42 M-16.08%
2007-03-31A$87.48 M-6.34%
2006-03-31A$93.4 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Sterling Infrastructure
STRL
A$5.02 B 37,809.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
A$12.05 B 90,743.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
A$6.90 B 51,929.18%๐Ÿ‡บ๐Ÿ‡ธ USA